Spineguard Stock Fundamentals
| ALSGD Stock | EUR 0.21 0.01 4.55% |
Spineguard fundamentals help investors to digest information that contributes to Spineguard's financial success or failures. It also enables traders to predict the movement of Spineguard Stock. The fundamental analysis module provides a way to measure Spineguard's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Spineguard stock.
Spineguard |
Spineguard Company Current Valuation Analysis
Spineguard's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Spineguard Current Valuation | 18.77 M |
Most of Spineguard's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Spineguard is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Spineguard has a Current Valuation of 18.77 M. This is 99.87% lower than that of the Health Care Equipment & Supplies sector and 99.85% lower than that of the Health Care industry. The current valuation for all France stocks is 99.89% higher than that of the company.
Spineguard Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Spineguard's current stock value. Our valuation model uses many indicators to compare Spineguard value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Spineguard competition to find correlations between indicators driving Spineguard's intrinsic value. More Info.Spineguard is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Spineguard's earnings, one of the primary drivers of an investment's value.Spineguard Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Spineguard's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Spineguard could also be used in its relative valuation, which is a method of valuing Spineguard by comparing valuation metrics of similar companies.Spineguard is currently under evaluation in current valuation category among its peers.
Spineguard Fundamentals
| Return On Equity | -0.43 | |||
| Return On Asset | -0.082 | |||
| Profit Margin | (0.44) % | |||
| Operating Margin | (0.33) % | |||
| Current Valuation | 18.77 M | |||
| Shares Outstanding | 31.71 M | |||
| Shares Owned By Institutions | 1.27 % | |||
| Price To Earning | (4.81) X | |||
| Price To Book | 3.68 X | |||
| Price To Sales | 4.11 X | |||
| Revenue | 4.41 M | |||
| Gross Profit | 3.61 M | |||
| EBITDA | (812.46 K) | |||
| Net Income | (1.72 M) | |||
| Cash And Equivalents | 1.06 M | |||
| Cash Per Share | 0.16 X | |||
| Total Debt | 3.61 M | |||
| Debt To Equity | 567.90 % | |||
| Current Ratio | 1.17 X | |||
| Book Value Per Share | 0.16 X | |||
| Cash Flow From Operations | (1.16 M) | |||
| Earnings Per Share | (0.08) X | |||
| Target Price | 1.6 | |||
| Number Of Employees | 21 | |||
| Beta | 2.71 | |||
| Market Capitalization | 33.05 M | |||
| Total Asset | 11.9 M | |||
| Z Score | 5.4 | |||
| Net Asset | 11.9 M |
About Spineguard Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Spineguard's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Spineguard using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Spineguard based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.The companys PediGuard products are handheld devices that detect possible vertebral cortex perforation during pedicle preparation for screw placement, and alerts surgeons prior to a breach by analyzing the electrical conductivity of the surrounding tissues in real time. SpineGuard SA was founded in 2009 and is headquartered in Vincennes, France. SPINEGUARD operates under Medical Devices classification in France and is traded on Paris Stock Exchange. It employs 19 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Spineguard Stock Analysis
When running Spineguard's price analysis, check to measure Spineguard's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spineguard is operating at the current time. Most of Spineguard's value examination focuses on studying past and present price action to predict the probability of Spineguard's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spineguard's price. Additionally, you may evaluate how the addition of Spineguard to your portfolios can decrease your overall portfolio volatility.